Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3257)
All Articles published online
|
Nov 15, 2010 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim SW, Baik SH, Yoon KH, Lee HW, Filozof C. Efficacy and safety of vildagliptin/pioglitazone combination therapy in Korean patients with diabetes. World J Diabetes 2010; 1(5): 153-160 [PMID: 21537443 DOI: 10.4239/wjd.v1.i5.153] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v1/i5/153.htm |
| Number | Citing Articles |
| 1 |
David C. Klonoff, Lawrence Blonde, George Cembrowski, Antonio Roberto Chacra, Guillaume Charpentier, Stephen Colagiuri, George Dailey, Robert A. Gabbay, Lutz Heinemann, David Kerr, Antonio Nicolucci, William Polonsky, Oliver Schnell, Robert Vigersky, Jean-François Yale. Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes. Journal of Diabetes Science and Technology 2011; 5(6): 1529 doi: 10.1177/193229681100500630
|
| 2 |
Rowaida Refaat, Ahmed Sakr, Mona Salama, Ashgan El Sarha. Combination of Vildagliptin and Pioglitazone in Experimental Type 2 Diabetes in Male Rats. Drug Development Research 2016; 77(6): 300 doi: 10.1002/ddr.21324
|
| 3 |
Hamisi M Mraja, Sever Caglar, Muhammed Uslu, Bilal Yilmaz, Mustafa Fatih Dasci, Elif Yaprak Sarac, Metehan Demirkol. Effects of Linagliptin and Pioglitazone on Fracture Healing in an Experimental Type 2 Diabetes Rat Model. Cureus 2022; doi: 10.7759/cureus.32204
|
| 4 |
Suhas Erande, Jotideb Mukhopadhyay, Amol Dange, Anushka Deogaonkar, Ashish Birla, Chetan Doshi, Santosh Revankar, Sridhar S B, Neeraj Kumar, Pramod V Kadam. Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study. Cureus 2023; doi: 10.7759/cureus.44548
|
| 5 |
Pravesh Kumar Bundhun, Girish Janoo, Abhishek Rishikesh Teeluck, Feng Huang. Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. BMC Pharmacology and Toxicology 2017; 18(1) doi: 10.1186/s40360-017-0175-0
|